Author Correction: Structure-Activity Relationships of Baicalein and its Analogs as Novel TSLP Inhibitors

Correction to: Scientific Reports 10.1038/s41598-019-44853-5, published online 19 June 2019

The authors of this Article neglected to cite a paper which reported the crystal structure of hTLSP, which should be cited as below:

In the Results and Discussion section, under subheading ‘Binding of compound 1 to hTLSP’,

“Docking studies of 1 with hTSLP suggested that 1 bound to the hTSLPR-binding interface of hTSLP.”

should read:

“Docking studies of 1 with hTSLP suggested that 1 bound to the hTSLPR-binding interface of hTSLP¹.”

In the Experimental Procedures section, under subheading ‘Docking simulations’,

“Human TSLP structure (PDB ID: 5J11) was prepared using Gasteiger charge, protein structure was kept rigid in docking, and binding site of compound 1 was defined from CSP-mapped residues obtained from NMR binding experiments.”

should read:

“Human TSLP structure (PDB ID: 5J11) was prepared using Gasteiger charge, protein structure was kept rigid in docking, and binding site of compound 1 was defined from CSP-mapped residues obtained from NMR binding experiments¹.”